Institutional investors purchased a net $6.5 million shares of OMER during the quarter ended March 2015 and now own 58.91% of the total shares outstanding. This majority interest is a greater percentage than is typical for companies in the Biotechnology industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
INVESCO POWERSHARES CAPITAL MANA... Bought 3.0 Million shares of Omeros Corp
FIDELITY MANAGEMENT & RESEARCH C... Bought 1.3 Million shares of Omeros Corp
RA CAPITAL MANAGEMENT LLC Bought 749.0 Thousand shares of Omeros Corp